Masimo Debt to Equity Ratio 2010-2024 | MASI
Current and historical debt to equity ratio values for Masimo (MASI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Masimo debt/equity for the three months ending September 30, 2024 was 0.50.
| Masimo Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-09-30 | $1.63B | $1.46B | 1.11 |
| 2024-06-30 | $1.53B | $1.37B | 1.11 |
| 2024-03-31 | $1.59B | $1.37B | 1.17 |
| 2023-12-31 | $1.68B | $1.37B | 1.23 |
| 2023-09-30 | $1.72B | $1.28B | 1.35 |
| 2023-06-30 | $1.70B | $1.31B | 1.30 |
| 2023-03-31 | $1.79B | $1.33B | 1.34 |
| 2022-12-31 | $1.87B | $1.34B | 1.40 |
| 2022-09-30 | $1.80B | $1.25B | 1.44 |
| 2022-06-30 | $1.76B | $1.20B | 1.46 |
| 2022-03-31 | $0.33B | $1.58B | 0.21 |
| 2021-12-31 | $0.34B | $1.55B | 0.22 |
| 2021-09-30 | $0.30B | $1.47B | 0.20 |
| 2021-06-30 | $0.29B | $1.39B | 0.21 |
| 2021-03-31 | $0.27B | $1.33B | 0.20 |
| 2020-12-31 | $0.31B | $1.41B | 0.22 |
| 2020-09-30 | $0.30B | $1.42B | 0.21 |
| 2020-06-30 | $0.29B | $1.35B | 0.22 |
| 2020-03-31 | $0.22B | $1.25B | 0.18 |
| 2019-12-31 | $0.23B | $1.17B | 0.20 |
| 2019-09-30 | $0.21B | $1.11B | 0.19 |
| 2019-06-30 | $0.19B | $1.04B | 0.18 |
| 2019-03-31 | $0.17B | $1.01B | 0.17 |
| 2018-12-31 | $0.19B | $0.97B | 0.19 |
| 2018-09-30 | $0.18B | $0.91B | 0.20 |
| 2018-06-30 | $0.18B | $0.83B | 0.22 |
| 2018-03-31 | $0.18B | $0.77B | 0.24 |
| 2017-12-31 | $0.18B | $0.72B | 0.25 |
| 2017-09-30 | $0.19B | $0.72B | 0.26 |
| 2017-06-30 | $0.19B | $0.71B | 0.26 |
| 2017-03-31 | $0.24B | $0.63B | 0.38 |
| 2016-12-31 | $0.26B | $0.56B | 0.47 |
| 2016-09-30 | $0.31B | $0.33B | 0.92 |
| 2016-06-30 | $0.31B | $0.30B | 1.04 |
| 2016-03-31 | $0.35B | $0.27B | 1.32 |
| 2015-12-31 | $0.33B | $0.28B | 1.18 |
| 2015-09-30 | $0.31B | $0.27B | 1.15 |
| 2015-06-30 | $0.30B | $0.28B | 1.06 |
| 2015-03-31 | $0.25B | $0.33B | 0.77 |
| 2014-12-31 | $0.26B | $0.31B | 0.84 |
| 2014-09-30 | $0.25B | $0.28B | 0.87 |
| 2014-06-30 | $0.18B | $0.32B | 0.56 |
| 2014-03-31 | $0.11B | $0.35B | 0.30 |
| 2013-12-31 | $0.11B | $0.33B | 0.34 |
| 2013-09-30 | $0.11B | $0.31B | 0.36 |
| 2013-06-30 | $0.10B | $0.29B | 0.35 |
| 2013-03-31 | $0.11B | $0.28B | 0.38 |
| 2012-12-31 | $0.10B | $0.28B | 0.36 |
| 2012-09-30 | $0.10B | $0.31B | 0.30 |
| 2012-06-30 | $0.09B | $0.30B | 0.29 |
| 2012-03-31 | $0.10B | $0.28B | 0.37 |
| 2011-12-31 | $0.09B | $0.28B | 0.31 |
| 2011-09-30 | $0.08B | $0.30B | 0.26 |
| 2011-06-30 | $0.07B | $0.28B | 0.26 |
| 2011-03-31 | $0.07B | $0.26B | 0.29 |
| 2010-12-31 | $0.08B | $0.23B | 0.35 |
| 2010-09-30 | $0.08B | $0.25B | 0.32 |
| 2010-06-30 | $0.07B | $0.23B | 0.33 |
| 2010-03-31 | $0.08B | $0.21B | 0.40 |
| 2009-12-31 | $0.07B | $0.29B | 0.23 |
| 2009-09-30 | $0.07B | $0.27B | 0.24 |
| 2009-06-30 | $0.06B | $0.25B | 0.25 |
| 2009-03-31 | $0.07B | $0.24B | 0.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.917B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.078B | 26.12 |
| Intuitive Surgical (ISRG) | United States | $183.628B | 96.01 |
| Alcon (ALC) | Switzerland | $45.117B | 31.76 |
| IQVIA Holdings (IQV) | United States | $40.157B | 22.12 |
| Edwards Lifesciences (EW) | United States | $39.608B | 24.62 |
| IDEXX Laboratories (IDXX) | United States | $34.672B | 40.83 |
| DexCom (DXCM) | United States | $26.799B | 40.36 |
| Waters (WAT) | United States | $22.960B | 33.95 |
| STERIS (STE) | Ireland | $22.437B | 25.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.922B | 0.00 |
| Hologic (HOLX) | United States | $18.696B | 19.73 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.376B | 12.70 |
| Sysmex ADR (SSMXY) | Japan | $11.851B | 37.16 |
| Globus Medical (GMED) | United States | $11.200B | 28.52 |
| Teleflex (TFX) | United States | $9.378B | 14.96 |
| Penumbra (PEN) | United States | $8.969B | 87.86 |
| Glaukos (GKOS) | United States | $7.755B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.126B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.542B | 25.75 |
| Inari Medical (NARI) | United States | $3.119B | 0.00 |
| TransMedics (TMDX) | United States | $2.898B | 91.86 |
| LivaNova (LIVN) | United Kingdom | $2.829B | 16.33 |
| Veracyte (VCYT) | United States | $2.811B | 85.09 |
| Nihon Kohden (NHNKY) | Japan | $2.519B | 15.68 |
| Tandem Diabetes Care (TNDM) | United States | $2.242B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.227B | 18.14 |
| Integra LifeSciences Holdings (IART) | United States | $2.060B | 10.77 |
| RxSight (RXST) | United States | $2.024B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.257B | 0.00 |
| Artivion (AORT) | United States | $1.233B | 113.23 |
| Pulse Biosciences (PLSE) | United States | $1.110B | 0.00 |
| OPKO Health (OPK) | United States | $1.025B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.963B | 16.37 |
| OrthoPediatrics (KIDS) | United States | $0.749B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.726B | 18.33 |
| Pacific Biosciences Of California (PACB) | United States | $0.722B | 0.00 |
| IRadimed (IRMD) | United States | $0.712B | 38.49 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.702B | 0.00 |
| AxoGen (AXGN) | United States | $0.672B | 0.00 |
| SiBone (SIBN) | United States | $0.669B | 0.00 |
| Paragon 28 (FNA) | United States | $0.605B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.485B | 0.00 |
| CVRx (CVRX) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.99 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.291B | 19.57 |
| Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
| NeuroPace (NPCE) | United States | $0.228B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Nevro (NVRO) | United States | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.186B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| 908 Devices (MASS) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 16.32 |
| EDAP TMS S.A (EDAP) | France | $0.105B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| LENSAR (LNSR) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |